Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatic Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Early research (Phase 1)Study completedNCT00805090
What this trial is testing

Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects

Who this might be right for
Renal Insufficiency, ChronicHepatic InsufficiencyHealthy
Javelin Pharmaceuticals 37
Early research (Phase 1)Study completedNCT01790607
What this trial is testing

An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy
Ono Pharma USA Inc 20
Early research (Phase 1)Study completedNCT05624710
What this trial is testing

Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Who this might be right for
Renal InsufficiencyKidney Diseases
Incyte Corporation 25
Early research (Phase 1)Study completedNCT01817985
What this trial is testing

Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 33
Early research (Phase 1)Study completedNCT07394309
What this trial is testing

Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls

Who this might be right for
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 30
Early research (Phase 1)Study completedNCT04454424
What this trial is testing

Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver Function

Who this might be right for
Endometriosis Related PainOveractive BladderDiabetic Neuropathic Pain+1 more
Bayer 37
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Not applicableLooking for participantsNCT07418008
What this trial is testing

The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)

Who this might be right for
Liver CirrhosisCognitive DysfunctionHepatic Encephalopathy+1 more
University of Malaya 230
Early research (Phase 1)Study completedNCT06402721
What this trial is testing

Learn About How BAY 3283142 Moves Into, Through, and Out of the Body After a Single Dose in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function

Who this might be right for
Chronic Kidney DiseaseHepatic Impairment
Bayer 24
Early research (Phase 1)Study completedNCT07342868
What this trial is testing

Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Who this might be right for
Chronic Hepatitis B Infections
Aligos Therapeutics 20